Market outlook remains weak; analysts flag selective stock opportunities

India's equity markets are expected to face headwinds in the near term, with analysts adopting a defensive stance on broad-based buying. The Nifty 50 and Sensex are likely to find support around the 22,200-22,400 level, while gains may be capped by resistance in the 23,000-23,300 band, according to market participants tracking the benchmark indices.

Despite the tepid overall outlook, select stocks are attracting investor interest. Divi's Laboratories, the pharmaceutical company, features among the recommended picks for those seeking exposure to fundamentally strong businesses during market weakness. Analysts suggest investors remain selective and focus on quality names with resilient earnings profiles.

The resistance zone around 23,000-23,300 is expected to prove challenging for any meaningful market recovery, suggesting that investors should remain cautious about aggressive buying at current levels. The identified support band provides a floor for the indices, but sustained upside momentum appears limited in the near term.

Market participants are advised to maintain discipline and focus on stock-specific opportunities rather than chasing broad market rallies. The current environment rewards selective picking and a focus on companies with strong fundamentals and earnings visibility.